Chair and Department of Biochemistry and Biotechnology, Medical University of Lublin, Chodzki 1 Street, 20-093 Lublin, Poland.
Mater Sci Eng C Mater Biol Appl. 2019 Apr;97:1036-1051. doi: 10.1016/j.msec.2019.01.061. Epub 2019 Jan 16.
Tissue engineered products (TEPs), which mean biomaterials containing either cells or growth factors or both cells and growth factors, may be used as an alternative to the autografts taken directly from the bone of the patients. Nevertheless, the use of TEPs needs much more understanding of biointeractions between biomaterials and eukaryotic cells. Despite the possibility of the use of in vitro cellular models for initial evaluation of the host response to the implanted biomaterial, it is observed that most researchers use cell cultures only for the evaluation of cytotoxicity and cell proliferation on the biomaterial surface, and then they proceed to animal models and in vivo testing of bone implants without fully utilizing the scientific potential of in vitro models. In this review, the most important biointeractions between eukaryotic cells and biomaterials were discussed, indicating molecular mechanisms of cell adhesion, proliferation, and biomaterial-induced activation of immune cells. The article also describes types of cellular models which are commonly used for biomaterial testing and highlights the possibilities and drawbacks of in vitro tests for biocompatibility evaluation of novel scaffolds. Finally, the review summarizes recent findings concerning the use of adult mesenchymal stem cells for TEP generation and compares the potential of bone marrow- and adipose tissue-derived stem cells in regenerative medicine applications.
组织工程产品(TEP)是指含有细胞或生长因子或同时含有细胞和生长因子的生物材料,可作为直接从患者骨中取出的自体移植物的替代品。然而,TEP 的使用需要更多地了解生物材料和真核细胞之间的生物相互作用。尽管可以使用体外细胞模型来初步评估宿主对植入生物材料的反应,但观察到大多数研究人员仅使用细胞培养物来评估生物材料表面的细胞毒性和细胞增殖,然后他们进行动物模型和体内骨植入物测试,而没有充分利用体外模型的科学潜力。在这篇综述中,讨论了真核细胞和生物材料之间最重要的生物相互作用,指出了细胞黏附、增殖和生物材料诱导免疫细胞活化的分子机制。文章还描述了常用于生物材料测试的细胞模型类型,并强调了体外测试在新型支架生物相容性评估中的可能性和缺点。最后,综述总结了最近关于使用成体间充质干细胞生成 TEP 的研究结果,并比较了骨髓和脂肪组织来源干细胞在再生医学应用中的潜力。